# Pardes Biosciences Inc. (PRDS)

Source: https://www.quantisnow.com/company/PRDS
Generated: 2026-11-07T21:58:51.695Z

- Ticker: PRDS
- Exchange: NASDAQ
- Sector: Health Care
- Industry:  Medicinal Chemicals and Botanical Products 
- IPO year: 2021
- Website: https://www.pardesbio.com

## About

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.

## Latest PRDS news and filings

- 2023-09-11 12:00 UTC [SEC Form 15-12G filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-pardes-biosciences-inc-4963086)
- 2023-09-01 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-pardes-biosciences-inc-4948830)
- 2023-09-01 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-pardes-biosciences-inc-4948822)
- 2023-08-31 21:22 UTC [SEC Form 4] [SEC Form 4: Tananbaum James B. returned 16,813,146 shares to the company and acquired 1,000 shares](https://www.quantisnow.com/insight/sec-form-4-tananbaum-james-b-returned-16813146-shares-to-4948437)
- 2023-08-31 21:17 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Pardes Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-pardes-biosciences-inc-amendment-4948386)
- 2023-08-31 18:55 UTC [SEC Form 4] [SEC Form 4: Wiggans Thomas G closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-wiggans-thomas-g-closing-all-direct-ownership-4947791)
- 2023-08-31 18:54 UTC [SEC Form 4] [SEC Form 4: Varney Michael David closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-varney-michael-david-closing-all-direct-ownership-4947790)
- 2023-08-31 18:52 UTC [SEC Form 4] [SEC Form 4 filed by Smaldone Alsup Laurie](https://www.quantisnow.com/insight/sec-form-4-filed-by-smaldone-alsup-laurie-4947788)
- 2023-08-31 18:49 UTC [SEC Form 4] [SEC Form 4 filed by Pottage John C Jr](https://www.quantisnow.com/insight/sec-form-4-filed-by-pottage-john-c-jr-4947787)
- 2023-08-31 18:47 UTC [SEC Form 4] [SEC Form 4: Lopatin Uri A closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-lopatin-uri-a-closing-all-direct-ownership-4947785)
- 2023-08-31 18:45 UTC [SEC Form 4] [SEC Form 4: Lobell J Jay closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-lobell-j-jay-closing-all-direct-ownership-4947780)
- 2023-08-31 18:44 UTC [SEC Form 4] [SEC Form 4: Lacy Elizabeth H. closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-lacy-elizabeth-h-closing-all-direct-ownership-4947777)
- 2023-08-31 18:41 UTC [SEC Form 4] [SEC Form 4: Henson Heidi closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-henson-heidi-closing-all-direct-ownership-in-4947772)
- 2023-08-31 18:36 UTC [SEC Form 4] [SEC Form 4 filed by Hamill Laura](https://www.quantisnow.com/insight/sec-form-4-filed-by-hamill-laura-4947763)
- 2023-08-31 18:32 UTC [SEC Form 4] [SEC Form 4 filed by Autor Deborah M.](https://www.quantisnow.com/insight/sec-form-4-filed-by-autor-deborah-m-4947760)
- 2023-08-31 18:23 UTC [SEC Form 4] [SEC Form 4: Auerbach Mark closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-auerbach-mark-closing-all-direct-ownership-in-4947748)
- 2023-08-31 13:19 UTC [SEC Form 25-NSE filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-pardes-biosciences-inc-4947142)
- 2023-08-31 13:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-pardes-biosciences-inc-4947115)
- 2023-08-31 13:03 UTC [SEC Form POS AM filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-pardes-biosciences-inc-4947098)
- 2023-08-31 13:01 UTC [SEC Form POS AM filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-pardes-biosciences-inc-4947085)
- 2023-08-31 12:59 UTC [SEC Form 8-K] [Pardes Biosciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/pardes-biosciences-inc-filed-sec-form-8-k-completion-of-acquisition-4947066)
- 2023-08-31 12:34 UTC [SEC Form SC 13E3/A filed by Pardes Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-pardes-biosciences-inc-amendment-4946966)
- 2023-08-31 12:30 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Pardes Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-pardes-biosciences-inc-amendment-4946955)
- 2023-08-31 12:15 UTC [Public Offering] [Pardes Biosciences Announces Closing of Tender Offer](https://www.quantisnow.com/insight/pardes-biosciences-announces-closing-of-tender-offer-4946893)
- 2023-08-28 16:11 UTC [SEC Form SC 13E3/A filed by Pardes Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-pardes-biosciences-inc-amendment-4940646)
- 2023-08-28 16:08 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Pardes Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-pardes-biosciences-inc-amendment-4940640)
- 2023-08-28 15:34 UTC [Market Insight] [MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share In Tender Offer For Pardes Biosciences](https://www.quantisnow.com/insight/medipacific-offering-213-per-share-plus-one-contingent-value-right-4940603)
- 2023-08-28 15:33 UTC [MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences](https://www.quantisnow.com/insight/medipacific-offering-213-per-share-plus-one-contingent-value-right-4940600)
- 2023-08-17 21:45 UTC [Market Chatter] [MediPacific Reports Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Pardes Biosciences Shares](https://www.quantisnow.com/insight/medipacific-reports-calculation-of-additional-price-per-share-and-extension-4913873)
- 2023-08-17 21:43 UTC [MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares](https://www.quantisnow.com/insight/medipacific-announces-calculation-of-additional-price-per-share-and-extension-4913860)
- 2023-08-17 21:11 UTC [SEC Form SC 13E3/A filed by Pardes Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-pardes-biosciences-inc-amendment-4913607)
- 2023-08-17 21:09 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Pardes Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-pardes-biosciences-inc-amendment-4913575)
- 2023-08-14 20:31 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-pardes-biosciences-inc-4895088)
- 2023-08-04 20:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-pardes-biosciences-inc-4850055)
- 2023-07-28 21:08 UTC [SEC Form SC 13E3 filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-sc-13e3-filed-by-pardes-biosciences-inc-4814364)
- 2023-07-28 21:04 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Pardes Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-pardes-biosciences-inc-4814341)
- 2023-07-23 00:07 UTC [Lifshitz Law PLLC Announces Investigations of HCCI, PRDS, NLTX, CCF](https://www.quantisnow.com/insight/lifshitz-law-pllc-announces-investigations-of-hcci-prds-nltx-ccf-4782879)
- 2023-07-18 15:00 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-july-18-2023-4765429)
- 2023-07-18 11:42 UTC [Analyst Downgrade] [Pardes Biosciences downgraded by JMP Securities](https://www.quantisnow.com/insight/pardes-biosciences-downgraded-by-jmp-securities-4763562)
- 2023-07-18 09:22 UTC [Market Insight] [JMP Securities Downgrades Pardes Biosciences to Market Perform](https://www.quantisnow.com/insight/jmp-securities-downgrades-pardes-biosciences-to-market-perform-4762902)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PRDS
- Earnings history: https://www.quantisnow.com/earnings/PRDS
- Dividend history: https://www.quantisnow.com/dividends/PRDS
- Insider transactions: https://www.quantisnow.com/insiders/PRDS
- Options chain: https://www.quantisnow.com/options/PRDS
- SEC 8-K filings only: https://www.quantisnow.com/company/PRDS/8-k
- RSS and alerts for PRDS: https://www.quantisnow.com/docs/rss-feeds.md